Papers Under Review ​

​​

• Dang L-H T, Petersen M, Krinsky-McHale SJ, Pang D, Zigman WB, Mapstone M, Silverman W, O'Bryant S, Schupf N, Lee JH.  Plasma neurofilament light protein (NfL) is a diagnostic and prognostic biomarker of Alzheimer’s Disease in adults with Down syndrome. JAMA Neurology.  (under review)

• Vu M*, Gross T*, Lott IT, Doran E, Lee JH, Schupf N, Silverman W, Dang L-H T, Bansal S, Li Y, Jayatilake M, Spitale R, Cheema A, Mapstone M for the Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS).  Evidence of Altered Lipid Metabolism in Adults with Down Syndrome and Alzheimer’s Disease. Nature Medicine.  (under review)

• Melgarejo Arias JD, Narkhede A, Leendertz R, Gaona C, Chavez CA, Pirela RV, Chacón IJ, deEurasquin GA, Mena LJ, Terwilliger JD, Lee JH, Maestre G, Brickman A. The impact of Steady and Pulsatile Components of Blood Pressure on White Matter Hyperintensities in Hispanics adults: Findings from the Maracaibo Aging Study.  Hypertension.  (under review)

• Alvarez EC, Leendertz R, Melgarejo JD, Gaona C Chavez CA; Pirela RV, Fernandez F, Diego VP, Terwilliger JD, Lee JH, Blangero J, de Erausquin GA, Brickman AM, Illes J, Maestre GE.  Incidental Findings in Brain MRI Scans in Low Socioeconomical Status Hispanics Adults: Prevalence, Type and Management. Neurology. (under review)

• Rakhimova S, Sharip A, Molkenov A, Kozhamkulov U, Shin J, Zinovyev A, Kim J-I, Seo J-S, Zhukov Y, Omarov M, Tuleutaev M, Rakhmetova V, Terwilliger JD, Lee JH, Zhumadilov Z, Akilzhanova A, Kairov U. Whole-transcriptome sequencing and analysis of differentially expressed genes from tumor tissues provide insights into mechanisms of esophageal squamous cell carcinoma progression. Molecular Genetics and Genomics (under review) 

• Schworer EK, Handen BL, Petersen M, O’Bryant S, Peven JC, Tudorascu DL, Lee L, Krinsky-McHale SJ, Hom C, Clare I, Christian BT, Schupf N, Lee JH, Silverman W, Head E, Mapstone M, Lott I, Ances B, Zaman S, Brickman AM, Lai F, Rosas HD, Hartley SL, and the Alzheimer's Biomarker Consortium-Down Syndrome. Cognitive and functional performance and plasma biomarkers of early Alzheimer’s disease pathology in Down syndrome. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring.  (under review)